These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12497800)

  • 21. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B; Fonseca V
    Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
    Cases A
    Nefrologia; 2004; 24 Suppl(6):62-72, 187-235. PubMed ID: 15696897
    [No Abstract]   [Full Text] [Related]  

  • 24. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity.
    Esposito K; Nicoletti G; Giugliano D
    J Endocrinol Invest; 2002; 25(7):646-9. PubMed ID: 12150343
    [No Abstract]   [Full Text] [Related]  

  • 27. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study.
    Chen L; Peeters A; Magliano DJ; Shaw JE; Welborn TA; Wolfe R; Zimmet PZ; Tonkin AM
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):740-5. PubMed ID: 18043293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity, abdominal obesity, and clustering of cardiovascular risk factors in South Korea.
    Park HS; Yun YS; Park JY; Kim YS; Choi JM
    Asia Pac J Clin Nutr; 2003; 12(4):411-8. PubMed ID: 14672864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dyslipidemia as cardiovascular and cerebrovascular risk factor: epidemiology and physiopathology].
    Ambrosio G; Bentivoglio M; Carluccio E; Sardone M
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):91-4. PubMed ID: 12497889
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the influence of variation in the ACE gene on the prospective risk of Type 2 diabetes in middle-aged men modified by obesity?
    Muthumala A; Gable DR; Palmen J; Cooper JA; Stephens JW; Miller GJ; Humphries SE
    Clin Sci (Lond); 2007 Dec; 113(12):467-72. PubMed ID: 17624939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic renal disease as cardiovascular risk factor].
    Hermans MM; Kooman JP; Stehouwer CD
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1614-8. PubMed ID: 18998268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Obstructive sleep apnea-related cardiovascular disease].
    Schulz R; Grebe M; Eisele HJ; Mayer K; Weissmann N; Seeger W
    Med Klin (Munich); 2006 Apr; 101(4):321-7. PubMed ID: 16607489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.
    Ishimitsu T; Tsukada K; Ohta S; Inada H; Minami J; Ono H; Matsuoka H
    Am J Kidney Dis; 2004 Sep; 44(3):466-75. PubMed ID: 15332219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secular trends in cardiovascular risk factors: developments are not encouraging].
    Brotons C
    Rev Esp Cardiol; 2006 Jul; 59(7):650-2. PubMed ID: 16938206
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular implications of obesity.
    Nichols N
    Can J Cardiovasc Nurs; 2006; 16(2):58-63. PubMed ID: 17153133
    [No Abstract]   [Full Text] [Related]  

  • 36. Obesity and the heart: redefinition of the relationship.
    Iacobellis G; Sharma AM
    Obes Rev; 2007 Jan; 8(1):35-9. PubMed ID: 17212794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular mortality and body weight].
    Parise P; Bigaroni A
    Recenti Prog Med; 1996; 87(7-8):325-30. PubMed ID: 8975334
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149(37):40. PubMed ID: 17918461
    [No Abstract]   [Full Text] [Related]  

  • 40. Obesity in childhood and cardiovascular risk.
    Burke V
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):831-7. PubMed ID: 16922816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.